Drug
Nirsevimab
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Extra Dose Administered | 82 | 25.1 | 26.3 | signal |
| 2 | Hypotonia | 15 | 18.3 | 18.4 | signal |
| 3 | Tachypnoea | 19 | 17.1 | 17.3 | signal |
| 4 | Cyanosis | 22 | 17.0 | 17.2 | signal |
| 5 | Expired Product Administered | 42 | 15.4 | 15.8 | signal |
| 6 | Respiratory Distress | 33 | 14.6 | 14.8 | signal |
| 7 | Syringe Issue | 18 | 12.5 | 12.6 | signal |
| 8 | Incorrect Dose Administered | 229 | 12.4 | 14.2 | signal |
| 9 | Incorrect Route Of Product Administration | 17 | 12.3 | 12.4 | signal |
| 10 | Poor Quality Product Administered | 10 | 11.9 | 12.0 | signal |
| 11 | Petechiae | 10 | 11.7 | 11.8 | signal |
| 12 | Wheezing | 41 | 8.4 | 8.6 | signal |
| 13 | Product Dispensing Error | 15 | 8.4 | 8.5 | signal |
| 14 | Erythema Multiforme | 6 | 7.8 | 7.9 | signal |
| 15 | Hyperbilirubinaemia | 5 | 5.9 | 5.9 | signal |
| 16 | Rhinorrhoea | 31 | 5.9 | 6.0 | signal |
| 17 | Injection Site Induration | 6 | 5.6 | 5.7 | signal |
| 18 | Pallor | 12 | 5.4 | 5.4 | signal |
| 19 | Product Storage Error | 38 | 5.4 | 5.5 | signal |
| 20 | Respiratory Arrest | 11 | 4.8 | 4.8 | signal |
| 21 | Crying | 14 | 4.7 | 4.7 | signal |
| 22 | Accidental Overdose | 13 | 4.3 | 4.4 | signal |
| 23 | Myelosuppression | 5 | 1.8 | 1.8 | no signal |
| 24 | Injection Site Rash | 4 | 1.6 | 1.6 | no signal |